Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1907223 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $0.20Day +3.97%Mkt cap $24MOff 52W high −63.8%Vol (1Y) 153.1%
Daily closing price, split-adjusted to the current basis; 0.3y shown of 85 bars on file. Sampled to 85 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest6.5% of sh out |
| Days to cover2.1d |
| 13F net flow (QoQ)+4.88% |
| Top-10 13F concentration95.0% |
| Next report (est.)2026-08-16 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$22.3M |
| ROE−198.2% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
No return windows available for GRML.
| Ann. volatility (1Y)153.1% |
| Ann. volatility (3Y)153.1% |
| Sharpe (1Y)−0.94 |
| Sharpe (3Y)−0.94 |
| Max drawdown (1Y)−66.3% |
| Max drawdown (3Y)−66.3% |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| METEORA CAPITAL, LLC | 5.4M | $2M | 4.43% | +76767828.6% |
| UBS Group AG | 1.1M | $354,089 | 0.89% | +107.7% |
| GEODE CAPITAL MANAGEMENT, LLC | 740,460 | $244,351 | 0.61% | +50.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | 577,276 | $190,501 | 0.48% | new |
| VANGUARD FIDUCIARY TRUST CO | 371,703 | $122,662 | 0.31% | new |
| Brummer Multi-Strategy AB | 370,049 | $122,116 | 0.31% | −39.0% |
| TWO SIGMA SECURITIES, LLC | 203,212 | $67,060 | 0.17% | new |
| AM INVESTMENT STRATEGIES LLC | 200,000 | $66,000 | 0.16% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-20 | −$0.15 | — | — | — |
| 2025-09-30 | 2025-11-13 | −$0.05 | — | — | — |
| 2025-06-30 | 2025-08-18 | −$0.12 | — | — | — |
| 2025-03-31 | 2025-05-15 | −$0.08 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-16 is ESTIMATED from filing cadence (median gap 88d) — not company-confirmed.
